Literature DB >> 32184221

β4-Nicotinic Receptors Are Critically Involved in Reward-Related Behaviors and Self-Regulation of Nicotine Reinforcement.

Marianne Husson1,2, Lauriane Harrington3,4, Léa Tochon1,2, Yoon Cho1,2, Inés Ibañez-Tallon5, Uwe Maskos3, Vincent David6,2.   

Abstract

Nicotine addiction, through smoking, is the principal cause of preventable mortality worldwide. Human genome-wide association studies have linked polymorphisms in the CHRNA5-CHRNA3-CHRNB4 gene cluster, coding for the α5, α3, and β4 nicotinic acetylcholine receptor (nAChR) subunits, to nicotine addiction. β4*nAChRs have been implicated in nicotine withdrawal, aversion, and reinforcement. Here we show that β4*nAChRs also are involved in non-nicotine-mediated responses that may predispose to addiction-related behaviors. β4 knock-out (KO) male mice show increased novelty-induced locomotor activity, lower baseline anxiety, and motivational deficits in operant conditioning for palatable food rewards and in reward-based Go/No-go tasks. To further explore reward deficits we used intracranial self-administration (ICSA) by directly injecting nicotine into the ventral tegmental area (VTA) in mice. We found that, at low nicotine doses, β4KO self-administer less than wild-type (WT) mice. Conversely, at high nicotine doses, this was reversed and β4KO self-administered more than WT mice, whereas β4-overexpressing mice avoided nicotine injections. Viral expression of β4 subunits in medial habenula (MHb), interpeduncular nucleus (IPN), and VTA of β4KO mice revealed dose- and region-dependent differences: β4*nAChRs in the VTA potentiated nicotine-mediated rewarding effects at all doses, whereas β4*nAChRs in the MHb-IPN pathway, limited VTA-ICSA at high nicotine doses. Together, our findings indicate that the lack of functional β4*nAChRs result in deficits in reward sensitivity including increased ICSA at high doses of nicotine that is restored by re-expression of β4*nAChRs in the MHb-IPN. These data indicate that β4 is a critical modulator of reward-related behaviors.SIGNIFICANCE STATEMENT Human genetic studies have provided strong evidence for a relationship between variants in the CHRNA5-CHRNA3-CHRNB4 gene cluster and nicotine addiction. Yet, little is known about the role of β4 nicotinic acetylcholine receptor (nAChR) subunit encoded by this cluster. We investigated the implication of β4*nAChRs in anxiety-, food reward- and nicotine reward-related behaviors. Deletion of the β4 subunit gene resulted in an addiction-related phenotype characterized by low anxiety, high novelty-induced response, lack of sensitivity to palatable food rewards and increased intracranial nicotine self-administration at high doses. Lentiviral vector-induced re-expression of the β4 subunit into either the MHb or IPN restored a "stop" signal on nicotine self-administration. These results suggest that β4*nAChRs provide a promising novel drug target for smoking cessation.
Copyright © 2020 the authors.

Entities:  

Keywords:  addiction; habenula; interpeduncular nucleus; nicotine; nicotinic receptors; reward

Year:  2020        PMID: 32184221      PMCID: PMC7178913          DOI: 10.1523/JNEUROSCI.0356-19.2020

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  68 in total

Review 1.  Nicotine addiction and nicotinic receptors: lessons from genetically modified mice.

Authors:  Jean-Pierre Changeux
Journal:  Nat Rev Neurosci       Date:  2010-06       Impact factor: 34.870

2.  Developmental regulation of nicotinic ACh receptor subunit mRNAs in the rat central and peripheral nervous systems.

Authors:  M Zoli; N Le Novère; J A Hill; J P Changeux
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

3.  Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment.

Authors:  M J Marks; J R Pauly; S D Gross; E S Deneris; I Hermans-Borgmeyer; S F Heinemann; A C Collins
Journal:  J Neurosci       Date:  1992-07       Impact factor: 6.167

4.  Co-activation of VTA DA and GABA neurons mediates nicotine reinforcement.

Authors:  S Tolu; R Eddine; F Marti; V David; M Graupner; S Pons; M Baudonnat; M Husson; M Besson; C Reperant; J Zemdegs; C Pagès; Y A H Hay; B Lambolez; J Caboche; B Gutkin; A M Gardier; J-P Changeux; P Faure; U Maskos
Journal:  Mol Psychiatry       Date:  2012-07-03       Impact factor: 15.992

5.  Neuronal and astrocyte expression of nicotinic receptor subunit beta4 in the adult mouse brain.

Authors:  Lorise C Gahring; Karina Persiyanov; Scott W Rogers
Journal:  J Comp Neurol       Date:  2004-01-12       Impact factor: 3.215

6.  Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors.

Authors:  Vincent David; Morgane Besson; Jean-Pierre Changeux; Sylvie Granon; Pierre Cazala
Journal:  Neuropharmacology       Date:  2006-03-31       Impact factor: 5.250

7.  A variant associated with nicotine dependence, lung cancer and peripheral arterial disease.

Authors:  Thorgeir E Thorgeirsson; Frank Geller; Patrick Sulem; Thorunn Rafnar; Anna Wiste; Kristinn P Magnusson; Andrei Manolescu; Gudmar Thorleifsson; Hreinn Stefansson; Andres Ingason; Simon N Stacey; Jon T Bergthorsson; Steinunn Thorlacius; Julius Gudmundsson; Thorlakur Jonsson; Margret Jakobsdottir; Jona Saemundsdottir; Olof Olafsdottir; Larus J Gudmundsson; Gyda Bjornsdottir; Kristleifur Kristjansson; Halla Skuladottir; Helgi J Isaksson; Tomas Gudbjartsson; Gregory T Jones; Thomas Mueller; Anders Gottsäter; Andrea Flex; Katja K H Aben; Femmie de Vegt; Peter F A Mulders; Dolores Isla; Maria J Vidal; Laura Asin; Berta Saez; Laura Murillo; Thorsteinn Blondal; Halldor Kolbeinsson; Jon G Stefansson; Ingunn Hansdottir; Valgerdur Runarsdottir; Roberto Pola; Bengt Lindblad; Andre M van Rij; Benjamin Dieplinger; Meinhard Haltmayer; Jose I Mayordomo; Lambertus A Kiemeney; Stefan E Matthiasson; Hogni Oskarsson; Thorarinn Tyrfingsson; Daniel F Gudbjartsson; Jeffrey R Gulcher; Steinn Jonsson; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

8.  α3β4 nicotinic acetylcholine receptors in the medial habenula modulate the mesolimbic dopaminergic response to acute nicotine in vivo.

Authors:  Sarah E McCallum; Matthew A Cowe; Samuel W Lewis; Stanley D Glick
Journal:  Neuropharmacology       Date:  2012-04-26       Impact factor: 5.250

Review 9.  Effect of nicotine and nicotinic receptors on anxiety and depression.

Authors:  Marina R Picciotto; Darlene H Brunzell; Barbara J Caldarone
Journal:  Neuroreport       Date:  2002-07-02       Impact factor: 1.837

10.  Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei.

Authors:  R Klink; A de Kerchove d'Exaerde ; M Zoli; J P Changeux
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

View more
  1 in total

1.  Divergent Roles of α5 and β4 Nicotinic Receptor Subunits in Food Reward and Nicotine-induced Weight Loss in Male Mice.

Authors:  Alberte Wollesen Breum; Sarah Falk; Charlotte Sashi Aier Svendsen; Trine Sand Nicolaisen; Cecilie Vad Mathiesen; Uwe Maskos; Christoffer Clemmensen
Journal:  Endocrinology       Date:  2022-07-01       Impact factor: 5.051

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.